Curia New York Inc, based in U.S.A, is a pharmaceutical company that stands out with its certifications from FDA, EDQM and WHO-GMP.
They are recognized for Curia- A partner for the pharma and biotech industries to improve patient outcomes & quality of life.
One of their notable products is RACEPINEPHRINE HYDROCHLORIDE, USP DRUG SUBSTANCE, with a corresponding US DMF Number 21716.
Remarkably, this DMF maintains an Active status since its submission on June 06, 2008, highlighting commitment to regulatory compliance.